Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer
Stopped Expansion cohort was not open
Conditions
- Recurrent Gynecological Cancer
- Metastatic Cervical Cancer
- Metastatic Ovarian Cancer
- Metastatic Vaginal Cancer
- Metastatic Vulvar Cancer
- Metastatic Endometrial Cancer
- Recurrent Cervical Carcinoma
- Recurrent Ovarian Carcinoma
- Recurrent Vaginal Cancer
- Recurrent Vulvar Cancer
- Recurrent Endometrial Cancer
Interventions
- DRUG: Durvalumab
- DRUG: Tremelimumab
- RADIATION: Radiation Therapy
Sponsor
Dana-Farber Cancer Institute
Collaborators